Research use onlyNot for human or veterinary use
Encore Bio Labs CartExplore catalog
ENCORE BIO LABSRESEARCH COLLECTION
SS-31 — complete Encore Bio Labs reference vialMATERIAL / 21

Reference artwork · Legacy packaging may be shown.
Listed identity and formats take precedence over the image.

Research material

SS-31

Look inside the mitochondrion, down to its inner membrane. SS-31 research focuses on cardiolipin, a lipid found there, and its connection with mitochondrial function. Biochemical and animal studies give this four-amino-acid peptide a distinct place in the science of cellular energy.

CAS
736992-21-5

Formats & reference pricing

USD
Listed formatReference price
10 mg$59 USD

Reference prices describe the listed formats. They do not confirm availability or constitute an offer for sale.

Review product documentation

For laboratory research only. Not for human or veterinary use.

About the reference identity

Four residues with structural distinctions

SS-31 is also known in chemical records as elamipretide. Its reference sequence contains four amino-acid residues, including D-arginine and a dimethylated tyrosine, followed by lysine and phenylalanine. These details show why counting residues alone is not enough: stereochemistry and residue modifications are part of the molecular identity.

Reference synonym
Elamipretide
Structural detail
Four residues, including modified amino acids

Reference identity only; not a test result for current inventory.

01 / Material overview

The specifications.

Catalog identity
SS-31
CAS
736992-21-5
Listed formats
10 mg
Reference price range
$59 USD
Intended setting
Qualified laboratory or institutional research
Inventory specifications
Independent inventory review pending

02 / Public regulatory context

Approved product and catalog boundaries.

Public FDA records can identify an approved prescription product containing elamipretide. They do not establish approval or equivalence of this SS-31 catalog material.

REGULATORY REFERENCE · STATUS REVIEWED OCT 2026SS-31 / ELAMIPRETIDE

An FDA-approved elamipretide product exists. This catalog material is separate.

FORZINITY is an FDA-approved prescription drug product containing elamipretide. SS-31 is a research name associated with elamipretide in public literature. This Encore Bio Labs SS-31 catalog listing is not represented as FORZINITY, FDA-approved, interchangeable, substitutable, or equivalent in formulation, sterility, potency, manufacturing controls, quality, or intended use.

Catalog identity
SS-31
Related public name
Elamipretide
CAS
736992-21-5
FDA-labeled product
FORZINITY
Catalog approval status
Not represented as an FDA-approved drug product
Approved-product equivalence
Not represented or established
Scope of this reference

The approved-product record is linked only to distinguish public regulatory information from this catalog listing. It is not reproduced as therapeutic, physiological-benefit, dosing, injection, preparation, administration, personal-use, or medical guidance for this material.

External public records

DailyMed · FORZINITY / elamipretide label FDA · FORZINITY approval announcement

03 / Supporting records

Documentation.

Read the Encore summary, the scope of related reports and the status of privacy-redacted supplier copies.

No authenticated certificate establishing current-inventory identity or specifications is published for SS-31 in this catalog.

Encore documentary summary · not a laboratory-issued COA

View SS-31 PDF downloads ↓
Report availability
2 related reports located
Formats & scope
One related report names SS-31 / Elamipretide 10 mg; another has no nominal sample quantity.
Report authenticity
Laboratory authentication pending
Inventory evidence review
Report-to-inventory correspondence has not been independently established. No purity, quantity or activity result is attributed to current inventory.
Outstanding review
Do not infer a 10 mg match for the report without a nominal sample quantity. Review identity and measurement scope separately.
Product-specific SDS
Not located in the reviewed PDF set; applicability and verification pending.

Document inventory reviewed October 6, 2026. Related reports were commissioned by third parties, not Encore. Original customer details and internal records are not included here.

Privacy-redacted supplier report

Supplier-provided laboratory report

Where prepared, these are copies redacted by Encore for privacy, not laboratory-issued public versions or Encore-commissioned tests. Analytical content is not replaced with Encore results.

SS-31 · Related reports

1 report · PDF available

English original · 3 pages · 0.6 MB

Open PDF Download PDF

Spanish translation · 6 pages · 0.6 MB

Open Spanish PDF Download Spanish PDF

Open PDF uses a new tab. Download PDF saves the same privacy-redacted packet.

Prepared by Encore; not issued or certified by the laboratory. Each translated page is followed by its English source page, preserving original graphs and signatures. The separate English original is unchanged.

Included scope and exclusions: The selected report names SS-31 / Elamipretide 10 mg and covers identity/purity, not measured net content. A separate report without a nominal sample quantity is not included as evidence for the listed 10 mg format.

Laboratory authentication pending. These related references are not independently authenticated certificates for current Encore inventory. Supplier confirmation does not resolve the scope or discrepancies listed above.

Copy preparation
2 source files in redacted review copies. Duplicate file formats are not additional tests.
Supplier sharing permission
Owner-confirmed for supplied reports; this does not imply a report exists for every product. Report authentication is a separate check.
Privacy review
Selected website copy redacted; residual identification risk remains. Retained references and copies elsewhere can still identify the original customer; redaction does not guarantee anonymity.
Downloads
Selected related-reference PDF available.
Laboratory-issued public copy
Not available. Encore-prepared redactions are not an issuer reissue.

Read the packet cover and each report’s scope and limitations. Outstanding review items above remain unresolved; PDF availability does not change verification status.

A public copy does not by itself verify current inventory. No laboratory replacement or delivery date is promised.

Explore summary & report status

04 / A closer look

Common questions.

01Which SS-31 formats and reference prices are listed?

10 mg: $59 USD. These are catalog quantities and reference prices, not usage instructions, stock confirmation or an offer for sale.

02Where can I find the SS-31 reports?

The Documentation section on this page includes Open PDF and Download PDF links to a 3-page English original containing 1 supplier-provided report. Read the covered sample formats and limitations beside the download. These privacy-redacted, third-party-commissioned copies are not laboratory reissues. Laboratory authentication and independent inventory review remain pending.

03Is this SS-31 catalog material FORZINITY?

No. FDA-approved FORZINITY contains elamipretide, a name associated with SS-31 in public literature, but this catalog material is not represented as FORZINITY, as an approved drug product, or as equivalent or substitutable.

04Does FORZINITY prescribing information apply to this catalog material?

No. FDA-approved labeling applies to the specific approved product and formulation described in that labeling. It does not establish the formulation, sterility, potency, manufacturing controls, quality, or intended use of this catalog material.

05Does this page make mitochondrial, therapeutic, dosing, injection, or administration claims?

No. This catalog page is limited to identity, regulatory context, catalog formats, and document status. It provides no physiological-benefit, therapeutic, dosing, injection, preparation, administration, personal-use, or medical guidance.

06Does the image establish the contents of a lot?

No. The image is owned Encore Bio Labs reference artwork and may show legacy packaging. Use the written identity and specifications, then verify the exact lot with supporting records.

Continue the collection

Next in the catalog.

View all materials